文献速递静脉血栓栓塞慢性静脉疾病

血栓倾向对髂股静脉镍钛支架置入后血栓后综合征患者临床结局的影响

Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-11-10

本研究回顾性分析2012-2017年单中心136例慢性血栓后静脉闭塞性疾病接受镍钛静脉支架置入的患者,随访至少18个月。结果显示,有无血栓倾向的患者在支架通畅率和再干预率上均无显著差异,提示血栓倾向不应作为髂股静脉支架置入的排除标准。

要点

  • 在规范抗凝方案下,血栓倾向患者不应被排除在髂股静脉支架置入之外。

核心结论

  • 在规范抗凝方案下,有无血栓倾向的患者接受深静脉支架置入后临床结局相似,血栓倾向不应成为髂股静脉支架置入的排除标准。

研究设计与样本

  • 回顾性单中心队列研究,纳入2012-2017年连续136例因慢性血栓后静脉闭塞性疾病接受镍钛静脉支架置入的患者,随访至少18个月,采用统一抗凝方案。

主要发现

  • 136例患者中,55例(40%)为诱发性深静脉血栓,81例(60%)为无诱发性深静脉血栓并接受血栓倾向检测。
  • 81例无诱发性深静脉血栓患者中,38例(47%)存在血栓倾向,其中遗传性19例(50%),获得性19例(50%)。
  • 136例患者中68例(50%)在随访期间需要再干预以维持支架通畅。

临床怎么用

  • 对于慢性血栓后静脉闭塞性疾病患者,即使存在血栓倾向,在规范抗凝治疗下仍可考虑髂股静脉支架置入。

局限性

  • 本研究为单中心回顾性研究,样本量有限,随访时间至少18个月,结论需更大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Thrombophilia is a prothrombotic condition that increases the risk of venous thromboembolism. It is unclear whether the presence of thrombophilia alters the clinical outcomes after deep venous stenting. The aim of the present study was to examine the relationship between thrombophilia and outcomes after stenting for post-thrombotic syndrome. METHODS: Consecutive patients (2012-2017) receiving a nitinol venous stent for chronic post-thrombotic venous occlusive disease with a minimum of 18 months of follow-up in one center using the same anticoagulation protocol were included. The clinical history and thrombophilia testing results were reviewed. The outcomes were stent patency, which was assessed using duplex ultrasonography at 24 hours, 2 and 6 weeks, 3 months, 6 months, and annually thereafter; and reinterventions, which were performed when the stent diameter was <50% or occluded. RESULTS: Of the 136 patients who had undergone intervention, 55 (40%) had had a provoked deep vein thrombosis (DVT) and 81 (60%) had had an unprovoked DVT and had therefore undergone thrombophilia testing. Of the 81 patients, 38 (47%) had had either inherited (n = 19; 50%) or acquired (n = 19; 50%) thrombophilia. Of the 136 patients who had undergone stenting, 68 had required reintervention (50%) during follow-up to maintain stent patency. Of the 55 patients with a provoked DVT, 29 (53%) had required reintervention. Of the 81 patients with an unprovoked DVT, 39 (48%) had required reintervention (P = .420). Of the 38 patients with unprovoked DVT and thrombophilia, 17 (45%) had required reintervention. Of the 43 patients with unprovoked DVT and no thrombophilia, 22 (51%) had required reintervention (P = .766). The cumulative patency rate was 80% for patients with provoked DVT and 88% for those with unprovoked DVT (P = .193). The presence of thrombophilia was not associated with patency loss (92% cumulative patency for patients with thrombophilia and 84% for patients without thrombophilia; P = .307). CONCLUSIONS: Using our anticoagulation protocol, patients with and without thrombophilia had similar clinical outcomes after deep venous stenting and should not be excluded from iliofemoral venous stenting. We found no significant differences in outcomes in conjunction with appropriate postoperative anticoagulation therapy.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Gwozdz AM, Doyle AJ, Hunt BJ, et al. Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33186751. doi:10.1016/j.jvsv.2020.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。